Orange Book product · Generic (ANDA)
HALOBETASOL PROPIONATE
HALOBETASOL PROPIONATE
At a glance
Aug 11, 2023
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Aug 11, 2023
2 yr 11 mo ago
Today
Pharmaceutical detail
Active ingredient
HALOBETASOL PROPIONATE
Strength
0.05%
Dosage form
AEROSOL, FOAM
Route
TOPICAL
TE code
Not listed
Application
ANDA 215266
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
Yes
Active-ingredient family
View full familyGeneric (ANDA) of HALOBETASOL PROPIONATE
- 2018BRYHALIBrand (NDA)
NDA 209355 · BAUSCH
- 2018LEXETTEBrand (NDA)
NDA 210566 · MAYNE PHARMA
- 2015ULTRAVATEBrand (NDA)
NDA 208183 · LACER PHARMA
- 1990ULTRAVATEBrand (NDA)
NDA 019967 · SUN PHARM INDS INC
- 1990ULTRAVATEBrand (NDA)
NDA 019968 · SUN PHARM INDS INC
- 2020HALOBETASOL PROPIONATEGeneric (ANDA)
ANDA 213560 · QUAGEN
- 2020HALOBETASOL PROPIONATEGeneric (ANDA)
ANDA 211464 · PADAGIS ISRAEL
- 2018HALOBETASOL PROPIONATEGeneric (ANDA)
ANDA 209978 · ENCUBE
- 2007HALOBETASOL PROPIONATEGeneric (ANDA)
ANDA 078162 · COSETTE PHARMS NC
- 2006HALOBETASOL PROPIONATEGeneric (ANDA)
ANDA 077721 · COSETTE
- 2005HALOBETASOL PROPIONATEGeneric (ANDA)
ANDA 077227 · SUN PHARMA CANADA
- 2005HALOBETASOL PROPIONATEGeneric (ANDA)
ANDA 077109 · COSETTE PHARMS NC
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
